103 related articles for article (PubMed ID: 2125256)
1. Significance of FCM-DNA measurement in detecting minimal residual disease in leukemia.
Zhang RX; Yao EG
Chin Med J (Engl); 1990 Oct; 103(10):826-30. PubMed ID: 2125256
[TBL] [Abstract][Full Text] [Related]
2. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.
Basso G; Veltroni M; Valsecchi MG; Dworzak MN; Ratei R; Silvestri D; Benetello A; Buldini B; Maglia O; Masera G; Conter V; Arico M; Biondi A; Gaipa G
J Clin Oncol; 2009 Nov; 27(31):5168-74. PubMed ID: 19805690
[TBL] [Abstract][Full Text] [Related]
3. The importance of blast cell DNA content for prognosis of childhood acute lymphoblastic leukemia.
Starý J; Hrodek O; Hausner P; Petráková A; Goetz P; Kreuger A
Neoplasma; 1990; 37(3):293-9. PubMed ID: 2370916
[TBL] [Abstract][Full Text] [Related]
4. [Detection of minimal residual disease in acute leukemias by flow cytometry].
Scolnik MP
Medicina (B Aires); 2000; 60 Suppl 2():83-6. PubMed ID: 11188938
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of DNA aneuploidy as a tumor marker].
Takamoto S
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2329-37. PubMed ID: 2751314
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance and prognostic detection of minimal residual disease in acute leukemias].
Deptała A; Widzyńska I; Kuratowska Z
Acta Haematol Pol; 1995; 26(4):413-20. PubMed ID: 8571743
[TBL] [Abstract][Full Text] [Related]
7. [Dynamically monitoring minimal residual disease in acute leukemia after complete remission by multiparameter flow cytometry and its relation with prognosis].
Sun NN; Gan SL; Sun H; Zhang QT; Liu YF; Xie XS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):339-42. PubMed ID: 23628028
[TBL] [Abstract][Full Text] [Related]
8. [Flow cytometry in the determination of DNA aneuploidy in patients with acute leukemias].
Shmarov DA; Kuchma IuM; Miterev GIu; Kozinets GI
Ter Arkh; 1996; 68(7):11-4. PubMed ID: 8928064
[TBL] [Abstract][Full Text] [Related]
9. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
Muñoz L; López O; Martino R; Brunet S; Bellido M; Rubiol E; Sierra J; Nomdedéu JF
Haematologica; 2000 Jul; 85(7):704-10. PubMed ID: 10897122
[TBL] [Abstract][Full Text] [Related]
10. [Predictable recurrence by regular monitoring minimal residual disease with flow cytometry in the patients with both AML and ALL: a single-center study of 163 cases].
Tong CR; Wang H; Yang JF; Lin YH; Zhang X; Zhao J; Fei XH; Gu JY; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):748-51. PubMed ID: 22339910
[TBL] [Abstract][Full Text] [Related]
11. Aneuploidy as a marker of minimal residual disease in leukemia.
Walle AJ; Niedermayer W
Cancer Detect Prev; 1985; 8(1-2):303-15. PubMed ID: 4064049
[TBL] [Abstract][Full Text] [Related]
12. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of early marrow response in childhood aneuploid acute lymphoblastic leukemia: flow cytometric DNA analysis versus standard morphology.
Finn LS; Hawkins DS; Rutledge JC; Patterson K
Pediatr Dev Pathol; 2004; 7(1):39-47. PubMed ID: 15255034
[TBL] [Abstract][Full Text] [Related]
14. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
[TBL] [Abstract][Full Text] [Related]
15. The use of receiver operating characteristic analysis for detection of minimal residual disease using five-color multiparameter flow cytometry in acute myeloid leukemia identifies patients with high risk of relapse.
Al-Mawali A; Gillis D; Lewis I
Cytometry B Clin Cytom; 2009 Mar; 76(2):91-101. PubMed ID: 18727068
[TBL] [Abstract][Full Text] [Related]
16. [A prognostic factor in childhood acute lymphoblastic leukemia: implication of cellular DNA contents. Children's Cancer and Leukemia Study Group].
Katano N; Tsurusawa M; Kawai S; Fujimoto T
Rinsho Ketsueki; 1989 Jul; 30(7):943-50. PubMed ID: 2810797
[TBL] [Abstract][Full Text] [Related]
17. Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.
Borowitz MJ; Pullen DJ; Winick N; Martin PL; Bowman WP; Camitta B
Cytometry B Clin Cytom; 2005 Nov; 68(1):18-24. PubMed ID: 16184615
[TBL] [Abstract][Full Text] [Related]
18. Minimal residual disease testing in acute leukemia by flow cytometry immunophenotyping: prognostic significance.
Ruiz-Argüelles GJ; Fernández-Lara D; Estrada-Gómez R; Manzano C; Ruiz-Delgado GJ; Pérez-Romano B; Ruiz-Argüelles A
Lab Hematol; 2007; 13(1):22-6. PubMed ID: 17353179
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of both detection of lymphoblasts in the period of early treatment and minimal residual disease in childhood acute lymphoblastic leukemia].
Tie LJ; Gu LJ; Song DL; Jiang LM; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Wang YP; Chen J
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):6-9. PubMed ID: 15946500
[TBL] [Abstract][Full Text] [Related]
20. [Importance of the detection of minimal residual disease in the management of acute leukemia].
Mód A; Tamáska J; Adám E; Gidáll J; Poros A; Király A; Natonek K; Pálóczi K; Hollán Z
Orv Hetil; 1991 Jun; 132(24):1291-6, 1299. PubMed ID: 1857605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
